Koers Wound Management Technologies Inc Other OTC
Aandelen
US98211X1063
Farmaceutische producten
Omzet 2024 * | 78 mln. 71,87 mln. | Omzet 2025 * | - | Marktkapitalisatie | 263 mln. 243 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -1 mln. -921K | Nettowinst (verlies) 2025 * | 4 mln. 3,69 mln. | EV/omzet 2024 * | 3,38 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-139
x | K/w-verhouding 2025 * |
54,5
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 39,95% |
Recentste transcriptie over Wound Management Technologies Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 11-04-18 |
Chief Tech/Sci/R&D Officer | - | 01-01-23 | |
Chief Tech/Sci/R&D Officer | 39 | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 01-01-22 |
Roszell Mack
BRD | Director/Board Member | 57 | 01-01-22 |
Eric Major
BRD | Director/Board Member | 55 | 01-06-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,59% | 727 mld. | |
-7,89% | 347 mld. | |
+15,66% | 319 mld. | |
+0,24% | 274 mld. | |
+13,47% | 238 mld. | |
+7,35% | 204 mld. | |
-6,42% | 203 mld. | |
+4,23% | 161 mld. | |
-1,70% | 160 mld. |